Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

Press releases published on August 4, 2026

2 hours ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

Indeterminate GlobeNewswire

2 hours ago

Sienna Reports Second Quarter 2026 Financial Results and Forms Redevelopment Joint Venture with Fiera Infrastructure

Indeterminate GlobeNewswire

2 hours ago

Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.

Indeterminate GlobeNewswire

2 hours ago

LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026

Indeterminate GlobeNewswire

2 hours ago

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights                                               

Indeterminate GlobeNewswire

2 hours ago

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Indeterminate GlobeNewswire

2 hours ago

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

2 hours ago

PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Amwell® Announces Results for the Second Quarter 2026

Indeterminate GlobeNewswire

2 hours ago

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

Indeterminate GlobeNewswire

2 hours ago

Sienna Forms Joint Venture With Fiera Infrastructure to Expedite Long-Term Care Redevelopments

Indeterminate GlobeNewswire

2 hours ago

Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

2 hours ago

LeMaitre Q2 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination

Indeterminate GlobeNewswire

3 hours ago

Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

3 hours ago

Acquisition of Own Shares

Indeterminate GlobeNewswire

3 hours ago

Inkoop van eigen aandelen

Indeterminate GlobeNewswire

3 hours ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results

Indeterminate GlobeNewswire